Not Yet RecruitingNot Applicable

Ovarian Reserve in Intensive Care Patients

75 participantsStarted 2025-06-15

Plain-language summary

Gastrointestinal, pulmonary, nephrological, cardiac, neurologic and psychological effects in critically ill patients followed in the intensive care unit have been shown in the literature. However, the effects on ovarian reserve in these patients have not been sufficiently investigated and studies investigating this issue are limited in the literature. The synthesis, release frequency and amplitude of reproductive hormones change under stress. In addition, changes in ovarian homeostasis affect ovarian reserve. The aim of this study was to evaluate ovarian reserve in critically ill patients followed up in the intensive care unit.

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-35 years of age * Female patients followed in the intensive care unit for more than 24 hours for internal or surgical reasons, * Women whose ovarian reserve is being evaluated, Exclusion Criteria: * Previous ovarian surgery, endometriosis, endometrioma, * History of chemotherapy, radiotherapy, * Ovarian cyst, malignancy and other ovarian pathologies, * Women with single ovary, * Women receiving hormone therapy, * Polycystic ovary syndrome, * Surgical intervention within the last 6 months, * History of drug, alcohol, substance use, * Women in pregnancy, puerperium, lactation, * History of vaccination within the last 6 months

What they're measuring

ovarian follicle count

Timeframe: 24 hour

Trial details

NCT IDNCT06999291

SponsorHaseki Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-15

Contact for this trial

emine yılmaz güler

905054525261 dr.emine.yilmaz@gmail.com

View on ClinicalTrials.gov More Anti-Mullerian Hormone Deficiency trials